Acceptability and Efficacy of Group Reminiscence Intervention in a Sample of Patients With Schizo… (NCT07512843) | Clinical Trial Compass
CompletedNot Applicable
Acceptability and Efficacy of Group Reminiscence Intervention in a Sample of Patients With Schizophrenia
Jordan38 participantsStarted 2025-02-01
Plain-language summary
The study aimed to test whether group reminiscence intervention for inpatients with schizophrenia is feasible, acceptable and preliminary effective. The effect of the intervention was evaluated on cognition, communication, and social function. Phase I was a multi-phase parallel study (n=38). The purpose of the study was to assess feasibility and preliminary efficacy by conducting an 8-week intervention with the participants. The study employed a single-group pretest-posttest evaluation. Phase II evaluated acceptability and performed a thematic analysis of semi-structured interviews conducted by a purposively selected subsample (N=8).
Who can participate
Age range
18 Years – 64 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18-65 with schizophrenia diagnosed by DSM-5-TR
* Clinically stable, no acute episode or hospitalization in past 30 days
* Adequate cognition, passed MMSE, able to engage and provide consent
* Able to attend group sessions and participate in reminiscence sessions
Exclusion Criteria:
* Severe cognitive impairment or intellectual disability
* Acute psychiatric symptoms or suicidal ideation
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial was testing a group reminiscence therapy — which uses personal memories as a tool — for people with schizophrenia who are hospitalized; could this kind of approach be appropriate or helpful for my situation, or is my stage of treatment different enough that it wouldn't apply?
2The trial was in Phase NA and focused heavily on feasibility measures like recruitment and retention rather than proving the therapy works — does that mean there isn't yet strong evidence of benefit, and should I be looking at more established treatments first?
3Since the trial is already completed and measured things like social functioning and communication satisfaction, has my care team seen or heard about the results, and do they think the findings are relevant to my care plan?
4The intervention was group-based and took place in a hospital setting — if something like this were available to me, how would the group format and inpatient requirement fit with where I am in my treatment right now?
5Given that autobiographical memory and cognition were central to what this trial was studying, do you think my own memory or cognitive challenges are significant enough that a reminiscence or cognitive remediation approach is worth exploring as part of my overall treatment?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Feasibility Indicators: Recruitment Retention Attrition Adherence Data completeness Adverse events.
Timeframe: 12 weeks
2
The Brief Interpersonal Communication Satisfaction Inventory (Com-Sat)